Abstract
Kirrel3 is a cell-adhesion molecule that instructs the formation of specific synapses during brain development in mouse and Kirrel3 variants may be risk factors for autism and intellectual disabilities in humans. Kirrel3 is predicted to undergo alternative splicing but brain isoforms have not been studied. Here, we present the first in-depth characterization of Kirrel3 isoform diversity in brain using targeted, long-read mRNA sequencing of mouse hippocampus. We identified 19 isoforms with predicted transmembrane and secreted forms and show that even rare isoforms generate detectable protein in the brain. We also analyzed publicly-available long-read mRNA databases from human brain tissue and found 11 Kirrel3 isoforms that, similar to mouse, encode transmembrane and secreted forms. In mice and humans, Kirrel3 diversity arises from alternative, independent use of protein-domain coding exons and alternative early translation-stop signals. Intriguingly, the alternatively spliced exons appear at branch points in the chordate phylogenetic tree, including one exon only found in humans and their closest living relatives, the great apes. Together, these results validate a simple pipeline for analyzing isoform diversity in genes with low expression and suggest that Kirrel3 function is fine-tuned by alternative splicing and may play a role in brain evolution.
- alternative splicing
- cell adhesion
- evolution
- Kirrel3
- synapse
Significance Statement
Kirrel3 is an important molecule for synapse and circuit formation with gene variants that are associated with neurodevelopmental disorders, yet Kirrel3 function remains largely unknown. Here, we report new isoforms of mouse and human Kirrel3, including secreted and transmembrane forms, that suggest a diverse repertoire of Kirrel3 actions. Importantly, we identified a new Kirrel3 exon only present in humans and the other great apes with potential to play an important role in circuit formation unique to these species.
Introduction
Proper wiring of the mammalian brain requires billions of neurons to form synaptic connections with specific neurons. During development, axons extend to correct brain regions and then synapse with suitable neuronal partners, a process largely governed by the cellular environment, morphology, and cell surface proteins. Cell surface proteins help the cell find matching and avoid nonmatching synaptic partners (Sanes and Zipursky, 2020; Südhof, 2021). They also function in development by contributing to synapse formation and, likely, continue to function throughout adulthood during synapse maintenance, transmission, and plasticity.
The combinatorial expression of synaptic cell surface proteins provides different cell types with a unique identity that can be further tuned by alternative splicing. Alternative splicing of synaptic molecules can affect their protein-protein interactions and intracellular signaling (Südhof, 2017; Ovando-Zambrano et al., 2019; Li et al., 2020; Gomez et al., 2021; Trotter et al., 2023). This, in turn, expands the functional repertoire of synaptic genes and adds a layer of regulatory control. Accordingly, splicing factors are important for all aspects of neural development including neuronal health and accurate neuronal wiring (Furlanis and Scheiffele, 2018; Traunmüller et al., 2023). Despite the emerging importance and widespread use of alternative splicing programs in synaptic proteins (Ray et al., 2020), isoform diversity has been characterized for relatively few cell adhesion proteins including Dscam, Neurexin, and the Neurexin binding partners Neuroligin, Teneurin, and Latrophilin (Hattori et al., 2008; Schreiner et al., 2014; Treutlein et al., 2014; Südhof, 2017; Ovando-Zambrano et al., 2019; Li et al., 2020; Gomez et al., 2021).
Kirrel3 is a single pass transmembrane protein in the immunoglobulin (Ig) superfamily with five extracellular Ig domains and an intracellular PDZ-binding domain. Kirrel3 mediates cell-adhesion and synapse formation via trans-cellular, homophilic interactions and is essential for normal brain connectivity in mice (Prince et al., 2013; Martin et al., 2015, 2017; Roh et al., 2017; Brignall et al., 2018; Taylor et al., 2020; J. Wang et al., 2021). The Kirrel3 gene is composed of many small exons predicted to undergo alternative splicing. So far, three isoforms were reported in skeletal muscle (Durcan et al., 2014), but Kirrel3 isoform diversity has not been tested in the brain. Understanding the alternative splicing program of Kirrel3 is expected to provide new insight to its function in synapse and circuit formation. In addition, understanding the alternative splicing of Kirrel3 may facilitate the study of disease mechanisms that involve this synaptic gene because human Kirrel3 missense variants have been repeatedly identified as risk factors for neurodevelopmental disorders including autism spectrum disorders and intellectual disabilities (Bhalla et al., 2008; De Rubeis et al., 2014; Iossifov et al., 2014; T. Wang et al., 2016; Yuen et al., 2016; Li et al., 2017; Kalsner et al., 2018; Guo et al., 2019; Leblond et al., 2019; Hildebrand et al., 2020; Taylor et al., 2020; Zhou et al., 2022).
Here, we generated a comprehensive list of Kirrel3 isoforms expressed in the mouse hippocampus obtained with targeted long-read mRNA sequencing. In addition, we examined existing long-read transcriptome data from multiple mouse and human brain regions. We identified a total of 19 mouse and 11 human alternative transcripts predicted to encode distinct Kirrel3 proteins including secreted and transmembrane variants. In both mice and humans, Kirrel3 isoform diversity originates in the independent combination of four protein coding exons, two on the extracellular and two on the intracellular side, together with several alternative C termini. The four alternatively spliced protein coding exons first appear at different critical branching points in the chordate phylogenetic tree. Moreover, we identified a new alternatively spliced protein-coding Kirrel3 exon exclusively present in humans and the great apes (Hominidae), suggesting a key role of Kirrel3 in regulating brain connectivity in these closely related species.
Materials and Methods
Animals
Kirrel3 knock-out (KO) mice were described previously (Prince et al., 2013) and are backcrossed to the C57Bl/6J strain background. Male and female mice were used in equal numbers and described in the text. All animal experiments were approved and conducted in accordance with the University of Utah Institutional Animal Care and Use Committee (IACUC).
Iso-seq sample processing and analysis
RNA was purified from two whole hippocampi per sample and a total of six samples. Samples are from two C57Bl/6J P14 males and females, respectively, as well as one P14 male and female knock-out control (KO; Prince et al., 2013). RNA was tested for quality (Agilent TapeStation, RIN ≥ 8.0) and converted to cDNA (NEBNext Single Cell/Low Input RNA Library Prep kit for Illumina). cDNA from each sample was amplified and barcoded in a mild stringency PCR (20 cycles of 30 s at 98°C, 54°C and 72°C), using a target-specific forward primer matching exon 2 of mouse Kirrel3 and a universal cDNA-reverse primer (Extended Data Table 1-1). Barcoded PCR products ≥1 kb were enriched (ProNex beads) and quantified (TapeStation D5000). Equal amounts of each sample were combined into a single 500 ng SMRTbell library for full-length transcript sequencing on a single SMRTcell using the Sequel II system (Pacific Bio). Iso-seq analysis was performed using R and the R-package BioStrings (Lifschitz et al., 2022). Results were manually confirmed and aligned using ApE plasmid editor software (Davis and Jorgensen, 2022). In brief, Iso-seq reads were demultiplexed using unique 16-bp bar code sequences and no more than two mismatches as search pattern. This strategy unambiguously identified the sample origin for 85.8% of all reads. Preliminary inspection of Iso-seq Kirrel3 transcripts was performed by dividing the Kirrel3 gene (NCBI Gene ID: 67703, 550,823 bp) into 155-bp fragments, and screening Iso-seq full-length reads for the presence of any of the 3536 resulting fragments. The preliminary inspection revealed one new exon and seven new exon extensions for a total of 29 alternatively spliced genomic segments (Extended Data Table 2-1). Iso-seq reads with sample IDs were screened for each of these 29 segments with no more than 40% mismatches.
Sequence Read Archive (SRA) and phylogenetic analysis
Published mouse or human PacBio SMRT transcript libraries generated with brain derived tissues or cell lines were screened for Kirrel3 transcripts using the conserved exon 2 sequence and the NCBI blastn suite (Altschul et al., 1990). Similar to the analysis of mouse transcripts, human Kirrel3 transcripts were first inspected for the presence of any of 3772 elements, each 155 bp in length, that make up the human Kirrel3 gene (NCBI Gene ID: 84623, 584,513 bp). The preliminary inspection revealed three new exons and one new exon extension for a total of 27 alternatively spliced genomic segments (Extended Data Table 2-1). Similar to the Iso-seq analyses, mouse and human Kirrel3 transcripts were then examined for the presence of the respective alternatively spliced segments (≤40% mismatches) and manually aligned using BioStrings and ApE plasmid editor software, respectively. Phylogenetic analyses of mouse exons 6, 18, 19b, and 22 and human exons 3, 16, 17c, 19a, and 21 were performed by comparing nucleotide sequences to published genomes using the blastn suite (Altschul et al., 1990), direct gene ortholog inspection and by examining relationship of species with matches using the NCBI Taxonomy database (Schoch et al., 2020).
Fluorescent in situ hybridization chain reaction (HCR)
HCR was performed as previously described (Trivedi et al., 2018). Mouse brains were cryo-sectioned to 30-μm slices, mounted on slides, fixed [4% paraformaldehyde (PFA)] and washed in PBS. Before processing samples according to protocol HCR v3.0 (Invitrogen), slices were treated with 1 μg/ml proteinase K-treated (TE buffer) and equilibrated in SSC buffer. Custom HCR probes were designed and generated by Molecular Instruments based on provided targets (Extended Data Table 4-1). After nuclear staining with Hoechst in PBS, coverslips were mounted in Fluoromount-G (Southern Biotech catalog #0100-01) and imaged (Zeiss LSM 710).
Immunoblotting
Immunoblotting was conducted by standard techniques. Mouse samples are hippocampi from a three-week-old Kirrel3 wild-type or knock-out animals. Human samples are derived from deidentified postmortem dorsolateral prefrontal cortex stored at −80°C (kindly provided by Hilary Coon). Tissue samples are from one female (21 years, post mortem interval: 11.2 h) and one male (23 years, post mortem interval: 11.6 h). Mouse and human samples were processed in a Dounce homogenizer in lysis buffer (50 mm Tris, pH 7.5, 150 mm NaCl, 5 mm EDTA, 10% Glycerol, 1% CHAPS) with protease inhibitors at 100 mg/ml. The lysate was boiled in Laemmli buffer, run in a 10% bis-tris gel, and transferred to a nitrocellulose membrane. Antibodies used included mouse-anti-Pan-Kirrel3 (Neuromab, RRID: AB_2315857), mouse anti-Kirrel3exon19b (Neuromab, RRID: AB_2341106), mouse-anti-GAPDH (Millipore, catalog #AB2302, RRID: AB_10615768), and a custom rabbit anti-Kirrel3 made against a C-terminal peptide (Martin et al., 2015). Secondary antibodies were goat-anti-mouse-HRP (Jackson ImmunoResearch, catalog #115-035-003, RRID: AB_10015289) and goat-anti-rabbit-HRP (Jackson ImmunoResearch, catalog #111-036-003, RRID: AB_2337942).
DNA constructs
cDNAs and plasmids were generated using standard PCR-based restriction enzyme cloning (Taylor et al., 2020). Extracellular FLAG tags were added to mouse Kirrel3 Isoforms F (Kirrel3F) and K (Kirrel3K) in frame after the predicted signal-peptide cleavage site (exon 6) and the tagged constructs placed 3′ to mCherry or GFP followed by a viral 2A peptide sequence into the mammalian expression vector pBOS (mCherry-2A-FLAG-Kirrel3F/K).
Cell aggregation assay
CHO cells were transfected with either mCherry-2A-FLAG-Kirrel3F, mCherry-2A-FLAG-Kirrel3K, GFP-2A-FLAG-Kirrel3F, or pBOS with mCherry only (mCherry-pBOS). After 48 h, transfected cells were washed and detached (0.01% trypsin) in magnesium-free HEPES buffer (HMF; 137 mm NaCl, 5.4 mm KCl, 1 mm CaCl2, 0.34 mm Na2HPO4, 5.6 mm glucose, and 10 mm HEPES, pH 7.4), spun down, and resuspended in HMF. Next, 100 000 cells suspended in 0.5 ml HMF were allowed to aggregate for 90 min (nutator, 37°C) in BSA-coated 24-well plates. For analysis, cells are fixed by adding paraformaldehyde (PFA; 4% final) and allowed to settle over a 24-h period. All but 0.3 ml of the supernatant are removed, cells and cell aggregates are carefully transferred in the remaining volume to a 96-well glass bottom plate, and the entire well is imaged (Zeiss LSM 710). Finally, the fraction of aggregated cells in the entire well was determined using ImageJ software.
Immunocytochemistry and analysis
293T-HEK cells on poly-D-Lysine treated glass coverslips were transfected using PEI following a previously published protocol (Xie et al., 2013). After 24 h, cells were fixed (4% PFA) and rinsed with PBS and blocked for 30 min with 3% BSA/0.1% Triton X-100 in PBS (blocking buffer). Blocking buffer was also used for all subsequent washes and antibody dilutions. For antigen labeling, cells were incubated for 1–2 h with primary antibody at room temperature, washed three times, and incubated for 45 min with secondary antibody. After nuclear staining with Hoechst in PBS, coverslips were mounted in Fluoromount-G and imaged (Zeiss LSM 710). The relative enrichment of membrane proteins in cell-to-cell contacts was measured as ratio of average fluorescence pixel intensity along a cell’s contact versus free membrane using ImageJ software.
Statistics
For the CHO aggregation experiment, the sample size (n = 3 for all conditions) indicates independent experiments conducted on different days. Groups were compared by a one-way ANOVA followed by pair-wise post-tests. For the cell junctional enrichment assay, we sampled several cells from three independent cultures and used a nested one-way ANOVA followed by pair-wise post-tests.
Availability of data and materials
Iso-seq sequencing data are available at NCBI under SRA data file number PRJNA992104. Kirrel3 isoform sequence files have been deposited at NCBI. GenBank accession numbers for mouse Kirrel3 mRNA Isoforms F–T are OR239801–OR239815, respectively. All other materials and data that are not commercially available will be freely provided on reasonable request.
Results
A strategy to enrich for full-length Kirrel3 transcripts
Commonly used deep-sequencing technologies rely on short sequence reads (<250 bp) that are powerful assets in defining whole cell or tissue transcriptomes (Corchete et al., 2020). Short sequence reads are suitable to determine relative transcript frequencies and relative exon usage for all genes expressed. However, short-read sequencing is not suitable to directly determine the complete exon composition of transcripts longer than the 250-bp read limit (Leshkowitz et al., 2022). Recent advances in long-sequence read technologies such as Iso-seq (Kuo et al., 2017) or Nanopore sequencing (Y. Wang et al., 2021) can generate millions of high-quality reads of >15 kb that allow full-length transcript characterization. To capture full-length Kirrel3 transcripts, we performed Iso-seq experiments on RNA collected from hippocampal tissue from 14-d-old C57Bl/6J mice (n = 4, 2 males, and 2 females). As a synapse specificity molecule, Kirrel3 is not an abundant transcript nor protein. Based on published RNA sequencing data on mouse brain samples (Bioproject PRJDB7898, five replicates), we estimate that Kirrel3 transcripts comprise an extremely small proportion of the overall mRNA content (<0.001%). Therefore, before conducting long-read sequencing, we enriched libraries for Kirrel3 transcripts. We accomplished this via a PCR amplification step using a forward primer matching exon 2 of Kirrel3 and a universal reverse primer with the sequence AAGCAGTGGTATCAACGCAGAGT, which was originally ligated to all transcripts during cDNA synthesis (Fig. 1). In addition, a unique Iso-seq library bar code was added to each sample in this step to allow for simultaneous sequencing of all samples in a single sequencing run. We chose the target-specific primer because exon 2 contains the start codon required for all known and predicted Kirrel3 isoforms. We also conducted Iso-seq on samples from 14-d-old male and female Kirrel3 knock-out mice (Prince et al., 2013) as sequencing and data analyses controls. We find that our modified Iso-seq strategy using a Kirrel3-specific primer generated datasets with a total of 1,394,974 reads including 11,328 Kirrel3 reads (0.8%). Although Kirrel3 remains a small part of the total dataset, we estimate that Kirrel3 transcripts were enriched over 1600-fold on average compared with whole-transcriptome libraries from brain tissue.
Extended Data Table 1-1
Samples and their barcodes. Each sample represents whole hippocampi of two individuals. Sample cDNA was 5′ and 3′ barcoded using a Kirrel3-specific forward (5′ barcode-CTTCTGTGAAAGGAGCCCTTCT) and a universal reverse primer (3′ barcode-AAGCAGTGGTATCAACGCAGAGT). KO: homozygous Kirrel3 knock-out. Download Table 1-1, DOCX file.
Four independently spliced exons and alternative C termini generate a diversity of Kirrel3 transcripts
In our custom analysis pipeline, 85.8% of transcript reads could be assigned to a sample based on sample-specific barcodes (Fig. 1; Extended Data Table 1-1). The remaining 14.2% of all transcripts either contained incomplete or no bar code and were excluded from subsequent analyses. To uncover new Kirrel3 exons, we screened transcripts of each sample for the presence of any known Kirrel3 sequence, including predicted intron sequences (NCBI Gene ID: 67703). Consistent with our PCR strategy to enrich for Kirrel3 transcripts beginning at exon 2, exon 1 of Kirrel3 was absent in our Iso-seq dataset. Moreover, hippocampal Kirrel3 transcripts neither contained predicted exons 3 and 4 (ENSEMBL genome browser, ENSMUSG00000032036), nor previously published exon 5, but we included them in the overall gene structure shown in Figure 2A for completeness (Fig. 2A, dashed boxes). Analysis of Kirrel3 transcripts indicates a total of 22 exons, one of which was not previously reported (exon 10 in Fig. 2A). These exons are alternatively spliced to generate 19 distinct isoforms in mouse hippocampus. Five were previously identified and designated as Isoforms A–E. Using the same logic, new isoforms are identified with a letter (Fig. 2B,C). Based on our data, we also estimated the frequency of each isoform (Fig. 2A,B) and the cumulative frequency of each predicted protein domain (Fig. 2D).
Extended Data Table 2-1
Mouse and Human Kirrel3 exon sequences and databases analyzed. Sequences of the 22 mouse and 21 human Kirrel3 exons. Segments that extend an exon are labeled with the letter “b,” the respective nonextended exons are labeled with “a.” NCBI Sequence Read Archive (SRA) data used to search for mouse and human Kirrel3 transcripts. Download Table 2-1, DOCX file.
Kirrel3 exons found in hippocampal transcripts fall into three groups. The first group contains constitutive exons present in all isoforms found in the hippocampus (Fig. 2A–C, gray boxes). The second group are exons that are either fully included or skipped (exons 6, 18, 22). Exon 6 contains a signal-peptide cleavage site and is present in most transcripts. If exon 6 is skipped, an alternative signal peptide is predicted. As a consequence, slightly different extracellular N termini are generated dependent on the presence or absence of exon 6. The third group of exons (8, 9, 11, 13, 17, 19, and 20) are found in transcripts with either extended or nonextended 3′ ends, suggesting that they contain two alternative 3′ splice sites (Xia et al., 2006; Keren et al., 2010; Suñé-Pou et al., 2017). In Figure 2, segments that extend an exon are labeled with the letter “b,” the respective nonextended exons are labeled with “a.” If included in the transcript, six out of the seven b segments (8b, 9b, 11b, 13b, 17b, and 20b) introduce a stop-codon (Fig. 2A–C, white boxes) and produce an alternative C terminus in the Kirrel3 protein. Exons 8b, 9b, 11b, 13b, 17b, and the newly identified exon 10 (Fig. 2A, asterisks) are predicted to generate secreted proteins with different numbers of Ig-domains (Fig. 2D). In contrast, exon 20b is predicted to generate a transmembrane protein with a short intracellular domain lacking the Kirrel3 PDZ-binding domain. Exon 19b does not produce a protein stop, but codes for 25 additional amino acids just intracellular to the transmembrane domain.
The vast majority of isoforms (95%) contain exon 22 and, thus, encode transmembrane proteins with a C-terminal PDZ-binding domain. In contrast, the alternatively generated transmembrane protein with a short intracellular domain lacking a PDZ-binding domain is found in just over 1% of all transcripts. Together with exons 6, 18, and 19b, exon 22 is one of four alternatively spliced exons that appear to be included or excluded from Kirrel3 transcripts independent from each other.
We confirmed our findings by searching published Iso-seq transcript libraries for mouse hippocampus and other brain regions. We found a total of 2237 Kirrel3 transcripts distributed across 21 published mouse Iso-seq libraries (Extended Data Table 2-1) but did not detect additional isoforms. Finally, samples from Kirrel3 knock-out mouse controls produced the expected 5′ untranslated region (UTR) of exon 2 followed by an eGFP coding sequence, which is consistent with how these germline knock-out mice were constructed (Prince et al., 2013).
Different Kirrel3 protein isoforms are found in brain tissue
Next, we tested whether we could identify distinct Kirrel3-protein isoforms in brain tissue. We initially focused on the existence of isoforms with different intracellular domains because the predicted proteins can be easily resolved by size on a Western blotting. We used a pan-Kirrel3 antibody against the extracellular domain and an isoform-specific antibody that selectively recognizes isoforms containing the short intracellular domain caused by inclusion of exon 20b. We examined immunoblots of mouse hippocampal lysates using the pan-Kirrel3 antibody and detected two bands that run at the expected molecular weight for full length proteins with the long and short intracellular domains (Fig. 2E) in wild-type but not Kirrel3 KO tissue. We then blotted the same lysates using the antibody specific to the short intracellular domain only and observed a single band at the lower molecular weight. The results of the immunoblot demonstrate that distinct Kirrel3 isoforms can be identified in brain tissue and that both exon 20b and exon 22 containing mRNA isoforms give rise to proteins in the brain.
Exons 18, 20b, and 22 do not directly affect Kirrel3-mediated homophilic cell adhesion
Homophilic, transcellular binding is necessary for Kirrel3-mediated synapse formation (Taylor et al., 2020) and structural studies indicate that Kirrel3-Kirrel3 trans binding is mediated predominantly by its first, most N-terminal Ig-domain (J. Wang et al., 2021). However, accumulating evidence suggests that intracellular domains can allosterically alter the ligand-binding properties of extracellular domains, either directly by inducing conformation changes, indirectly via additional factors, or by altering the stoichiometric assembly of transmembrane receptors (Changeux and Christopoulos, 2017; Ortiz Zacarías et al., 2018; X. Wang et al., 2018; Lara et al., 2019). Moreover, a disease-associated missense variant in the intracellular domain was recently identified that significantly attenuates Kirrel3 trans-cellular binding (Taylor et al., 2020). Thus, we wondered whether the C-terminus choice of Kirrel3 affects homophilic cell-adhesion using an established in vitro cell aggregation assay. To test this, we generated expression plasmids encoding cDNAs for isoforms that contain exon 22 (Isoform F) or 20b (Isoform K; Fig. 2B). By comparing Isoforms F and K, we sought to also obtain information about whether the selectively spliced extracellular domain encoded by exon 18 affects the homophilic transcellular binding of Kirrel3. Exon 18 is present in Isoform K, but not in Isoform F. We found that suspended cells expressing either Kirrel3 Isoform F or K readily form homophilic and heterophilic aggregates, but control cells expressing mCherry do not (Fig. 3A,B; Extended Data Table 3-1). We also find that cells co-expressing Isoforms F and K aggregate (Fig. 3A,B; Extended Data Table 3-1). Similarly, both Kirrel3 isoforms are significantly enriched at cell-cell junctional membranes as compared with other membrane regions when both contacting cells express Kirrel3 (Fig. 3C–G; Extended Data Table 3-1). In contrast, neither membrane-GFP nor Neuroligin (a transmembrane protein that does not undergo homophilic binding in trans) are enriched at cell-cell junctional membranes as compared with other membranes (Fig. 3C–G). Of note, we confirmed that neither HEK293 nor CHO cells used in any of these assays endogenously express detectable levels of Kirrel3 protein (Extended Data Fig. 3-1). Together, these results show that Kirrel3 Isoforms F and K undergo homophilic trans-cellular binding and suggest that the inclusion or exclusion of exons 18, 20b, and 22 does not directly affect the ability of Kirrel3 to bind itself in trans.
Extended Data Figure 3-1
HEK293 and CHO cells do not express endogenous Kirrel3. Western blotting showing that HEK293 and CHO cell lines used here do not endogenously express detectable levels of Kirrel3 protein. Kirrel3 WT and KO mouse cortex samples were used as positive and negative controls. Download Figure 3-1, TIF file.
Extended Data Table 3-1
Data analyses. Details of statistical analyses used in Figure 3. Download Table 3-1, DOCX file.
Kirrel3 isoforms are co-expressed in situ
Next, we sought to test whether different cell types or even individual cells express different Kirrel3 isoforms using fluorescent mRNA in situ hybridization (FISH). Because Kirrel3 is not an abundant transcript and most of the alternatively spliced exons are very short, we again focused on the two longest alternatively spliced regions, which encode the alternative intracellular domains exon 22 and 20b. We generated hybridization chain reaction (HCR) FISH probes (Choi et al., 2018) selective to exons 22 and 20b and conducted FISH on brain sections of P14 wild-type and Kirrel3 knock-out tissue (Fig. 4; Extended Data Table 4-1). Consistent with previous reports (Lein et al., 2007; Taylor et al., 2020; Hisaoka et al., 2021), we find that Kirrel3 is expressed specifically by DG neurons and GABA neurons in the hippocampus. It is also expressed by many cells in the lateral posterior nucleus (LPN) of the thalamus (Fig. 4). As predicted by our sequencing results, exon 20b is less abundant than exon 22, but we did not observe obvious differences in the expression pattern of both alternatively spliced exons. When we used both probes simultaneously, we found that individual DG and GABA neurons often co-express both isoforms (Fig. 4I,J). FISH probes to smaller exons did not yield any obvious signal. This is likely a technical issue because Kirrel3 transcripts are not highly expressed and the specific probes are very short. Nonetheless, these findings argue against a cell type-specific use of alternative intracellular domains and suggests that most neurons express a mixture of Kirrel3 isoforms with and without a PDZ-binding domain.
Extended Data Table 4-1
Fluorescent in situ hybridization (FISH) probes. Sequences of probes used in FISH experiments. Download Table 4-1, DOCX file.
The use of independently spliced Kirrel3 modules is expanded in Hominidae
To examine the extent to which our findings for mouse Kirrel3 isoforms apply to humans, we searched publicly available human brain Iso-seq libraries for reads containing Kirrel3 exon 2 (ENSEMBL genome browser, ENSG00000149571) and identified a total of 1365 transcripts distributed across 19 published libraries. Similar to our strategy for mouse, we screened the identified transcripts for the presence of any Kirrel3 gene sequence (NCBI Gene ID: 84623), including predicted intron sequences. The screen revealed three human Kirrel3 exons and one exon extension not previously reported (Fig. 5A). The human Kirrel3 gene has 21 exons and five alternative C termini, appears slightly more compact than that of the mouse, and does not contain any exons with homology to predicted mouse exons 3–5. Nevertheless, humans have orthologues to the four alternatively spliced mouse Kirrel3 protein coding exons (Fig. 5A,B). This includes an alternative signal peptide, insertions just before and after the transmembrane domain, and a short intracellular domain that lacks a PDZ-binding domain. Humans also have Kirrel3 isoforms with a completely new insertion (exon 19a) that adds 30 unique amino acids to the intracellular domain. Intriguingly, across all sequenced genomes a homolog to exon 19a was found only in other great apes (including chimpanzees, orangutans, and gorillas), both based on nucleotide and amino acid sequence. Moreover, our search revealed a total of 9 human Kirrel3 transcript isoforms predicted to encode different proteins, including three forms of secreted Kirrel3 (Fig. 5B,C). The transcript isoforms are designated with a number following the nomenclature of the previously identified isoforms 1–3. Because Kirrel3 transcripts are relatively rare, it is likely that more human isoforms can be found in the future with deeper and targeted sequencing. Nonetheless, we probed lysates prepared from postmortem human prefrontal cortex tissue with an anti-Kirrel3 antibody that recognizes the longest form of Kirrel3 and find evidence that the protein is expressed in human brain (Fig. 5D).
Kirrel3 variants may be risk factors for autism spectrum disorder and intellectual disabilities in humans and we wondered whether identified disease-associated variants are located in specific exons or protein coding domains. We searched the SFARI database (Banerjee-Basu and Packer, 2010; Abrahams et al., 2013) and the literature for Kirrel3 missense mutations associated with autism or intellectual disabilities (Bhalla et al., 2008; De Rubeis et al., 2014; Iossifov et al., 2014; T. Wang et al., 2016; Yuen et al., 2016; Li et al., 2017; Kalsner et al., 2018; Guo et al., 2019; Leblond et al., 2019; Hildebrand et al., 2020; Taylor et al., 2020; Zhou et al., 2022). Out of the 25 mutations with the strongest predicted association to disease (Fig. 5E), the majority (15) are within the Kirrel3 Ig-domains 2–5. Interestingly, no mutation with a strong disease link was found in the N-terminal Ig-domain despite its prominent role in homophilic transcellular binding. The remaining mutations are found in one of the alternatively spliced protein modules coded by exon 3 (three mutations), exons 16 and 17c (one mutation each), and exon 21 (five mutations), suggesting important roles for these exons in Kirrel3 function.
Independently spliced Kirrel3 modules appear at branch points in the chordate phylogenetic tree
Inspired by the identification of an alternatively spliced Kirrel3 exon only present in humans and their closest living relatives, we examined the presence of all five alternatively spliced protein coding Kirrel3 segments using both nucleotide and amino acid-based searches across all published genomes. PDZ-binding domain coding exon 22 of mice first appears in combination with the Ig-domains characteristic for Kirrel3 in chordates that evolved over 500 million years ago (Holland, 2005; Fig. 6). Mouse exon 6, coding for the Kirrel3 N terminus with a cleavable signal peptide first appears in amniotes, a clade that marks the transition of tetrapods from aquatic to terrestrial habitats ∼300 million years ago (Benton and Donoghue, 2007). Mouse exons 18 and 19b, both encoding protein segments in juxtaposition to the transmembrane domain, first appear together in placental mammals which evolved in the late cretaceous around 90 million years ago (O’Leary et al., 2013). Finally, human exon 19a and its orthologues appear to be the latest addition to Kirrel3 ∼12–16 million years ago when the last common ancestor of all great apes lived (Chen and Li, 2001).
Discussion
Here, we detect an extensive repertoire of Kirrel3 mRNA isoforms in the mouse brain using a modified long-read sequencing strategy that substantially enriched Kirrel3 transcripts in the dataset. Gene-specific enrichment was an essential prerequisite to discover the extensive alternative splicing of Kirrel3, because expression of this target recognition molecule is inherently sparse and is often limited to a subset of cell types within a tissue. Consequently, we find that bulk and single cell sequencing datasets generally contain limited reads of Kirrel3 transcripts. Moreover, sequencing full-length transcripts was necessary because classic next generation sequencing generates only short reads that identify single or few exons, but not complete exon contigs. The use of long-read sequencing is particularly important for transcripts arising from exon-rich genes like Kirrel3 which features more than twice the exon count of the average gene in both mouse and human (Sakharkar et al., 2004). Because of the relatively high Kirrel3 exon count, it is not surprising that Kirrel3 isoform diversity arises from many different types of splicing events including, exon skipping, alternative 3′ exon splicing (mouse and human), and alternative 5′ exon splicing (human). These three forms of alternative splicing occur at frequencies for Kirrel3 that roughly match the proportions typical for mammalian splice events (38% exon skipping, 18% alternative 3′ splicing, 8% alternative 5′ splicing; Koren et al., 2007).
Importantly, we provide evidence that even rare Kirrel3 isoforms present in our full-length transcript dataset make detectable levels of mRNA and protein in the mouse brain. For example, exon 20b is present in only ∼1% of Kirrel3 transcripts, yet we can detect both the corresponding mRNA and protein in brain tissue using a selective in situ probe and antibody, respectively. Moreover, we demonstrate that exon 20b-containing transcripts give rise to proteins. Inclusion of exon 20b produces a Kirrel3 variant characterized by a truncated intracellular domain lacking the PDZ-binding domain typical for Kirrel3 and present in 95% of all isoforms. Despite the truncated tail, Kirrel3 isoforms with exon 20b are still capable of transcellular homophilic binding and can mediate cell-adhesion. The case of Kirrel3 exon 20b illustrates how the study of alternative splicing of synaptic receptors can directly instruct future studies. For example, it would be important to examine how Kirrel3 proteins with truncated tails alter and modulate the function of Kirrel3 isoforms with PDZ-binding domain in forming and maintaining synapses. Addressing this question would also shed new light on how neurons use PDZ-domains, a motif present in various scaffolding proteins known to organize and structure synapses.
In a similar vein, it will be important to study the function of secreted Kirrel3 isoforms that, together, constitute an estimated 4% of isoforms. Secreted Kirrel3 isoforms feature one or more Ig-domains and, thus, are predicted to undergo homophilic binding. It is possible that secreted Kirrel3 binds and sequesters transmembrane Kirrel3 variants and prevents their normal function in trans-cellular binding and signaling. Alternatively, secreted Kirrel3 could activate transmembrane Kirrel3 and trigger intracellular signals that are independent of cell-to-cell contact. Another key finding of the present study is that Kirrel3 alternatively uses several protein-coding exons (exons 6, 18, 19, and 22 in mouse) that fall on both the extracellular and intracellular sides of the protein. Other than the C-terminal PDZ-binding domain present in exon 22, the function of the other protein-coding exons remains unknown. However, it is reasonable to assume they are essential for Kirrel3 activity because mutations in the equivalent human domains are associated with disorders. Moreover, these domains first appear at critical branching points in chordate evolution. In this context, the newly discovered intracellular Kirrel3 exon encoding 30 amino acids present only in humans and other great apes is of particular interest as it could serve a synapse-related function unique to Hominidae.
Acknowledgments
Acknowledgments: We thank the University of Utah Bioinformatics Core and Dr. Martin Cuma at the Research Computing Center for support with data analysis. We also thank Dr. Arif H. M. Ullah and Dr. Hilary Coon for reagents, Arnulfo Tunon-Ortiz for help with the graphical abstract, and the entire Williams lab and Dr. Alex Shcheglovitov for comments on the manuscript.
Footnotes
The authors declare no competing financial interests.
This work was supported by National Institutes of Health Grants MH125943 (to M.E.W.) and MH126241 (to D.T.).
- Received July 17, 2023.
- Revision received November 9, 2023.
- Accepted November 13, 2023.
- Copyright © 2023 Traenkner et al.
This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.